Correlation Between Fubon MSCI and CHO Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and CHO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and CHO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and CHO Pharma, you can compare the effects of market volatilities on Fubon MSCI and CHO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of CHO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and CHO Pharma.

Diversification Opportunities for Fubon MSCI and CHO Pharma

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fubon and CHO is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and CHO Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHO Pharma and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with CHO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHO Pharma has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and CHO Pharma go up and down completely randomly.

Pair Corralation between Fubon MSCI and CHO Pharma

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 0.41 times more return on investment than CHO Pharma. However, Fubon MSCI Taiwan is 2.43 times less risky than CHO Pharma. It trades about -0.03 of its potential returns per unit of risk. CHO Pharma is currently generating about -0.01 per unit of risk. If you would invest  14,300  in Fubon MSCI Taiwan on September 13, 2024 and sell it today you would lose (125.00) from holding Fubon MSCI Taiwan or give up 0.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Fubon MSCI Taiwan  vs.  CHO Pharma

 Performance 
       Timeline  
Fubon MSCI Taiwan 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Fubon MSCI may actually be approaching a critical reversion point that can send shares even higher in January 2025.
CHO Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CHO Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Fubon MSCI and CHO Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fubon MSCI and CHO Pharma

The main advantage of trading using opposite Fubon MSCI and CHO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, CHO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHO Pharma will offset losses from the drop in CHO Pharma's long position.
The idea behind Fubon MSCI Taiwan and CHO Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Volatility Analysis
Get historical volatility and risk analysis based on latest market data